C3 and lobular neoplasia: Autoantibodies to double-stranded DNA (dsDNA), and markers of complement activation such as C3 and C4, are widely utilized in clinical practice in the diagnosis and surveillance of patients with LN, and these LN biomarkers were evidently used in this study.